Abstract
THE nuclear receptor superfamily includes receptors for steroids, retinoids, thyroid hormone and vitamin D, as well as many related proteins1,3. An important feature of the action of the lipophilic hormones and vitamins is that the maintenance of homeostatic function requires both intrinsic positive and negative regulation4,5. Here we provide in vitro and in vivo evidence that identifies the CREB-binding protein (CBP) and its homologue P300 (refs 6, 7) as cofactors mediating nuclear-receptor-activated gene transcription. The role of CBP/P300 in the transcrip-tional response to cyclic AMP, phorbol esters, serum, the lipophilic hormones and as the target of the E1A oncoprotein suggests they may serve as integrators of extracellular and intracellular signalling pathways.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
196,21 € per year
only 3,85 € per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Mangelsdorf, D. J. et al. Cell 83, 835–839 (1995).
Evans, R. M. Science 240, 889–895 (1988).
Green, S. & Chambon, P. Trends. Genet. 4, 309–314 (1988).
Mangelsdorf, D. J. & Evans, R. M. Cell 83, 841–850 (1995).
Casanova, J. et al. Mol. Cell. Biol. 14, 5756–5765 (1994).
Chrivia, J. C. et al. Nature 365, 855–859 (1993).
Eckner, R. et al. Genes Dev. 8, 869–884 (1994).
Chen, J. D. & Evans, R. M. Nature 377, 454–457 (1995).
Hörlein, A. J. et al. Nature 377, 397–404 (1995).
Oñate, S. A., Tsai, S. Y., Tsai, M. J. & O'Malley, B. W. Science 270, 1354–1357 (1995).
Lee, J. W., Ryan, F., Swaffield, J. C., Johnston, S. A. & Moore, D. D. Nature 374, 91–94 (1995).
vom Baur, E. et al. EMBO J. 15, 110–124 (1995).
Cavaillès, V. et al. EMBO J. 14, 3741–3751 (1995).
Halachmi, S. et al. Science 264, 1455–1458 (1994).
Le Douarin, B. et al. EMBO J. 14, 2020–2033 (1995).
Schüle, R. & Evans, R. M. Trends Genet. 7, 377–381 (1991).
Arias, J. et al. Nature 370, 226–229 (1994).
Hill, C. S. & Treisman, R. Cell 80, 199–211 (1995).
Schulman, I. G., Chakravarti, D., Juguilon, H., Romo, A. & Evans, R. M. Proc. Natl Acad. Sci. USA 92, 8288–8292 (1995).
Parker, D. et al. Mol. Cell. Biol. 16, 694–703 (1996).
Forman, B. M., Umesono, K., Chen, J. & Evans, R. M. Cell 81, 541–550 (1995).
Forman, B. M. et al. Cell 81, 687–693 (1995).
Umesono, K., Murakami, K. K., Thompson, C. C. & Evans, R. M. Cell 65, 1255–1266 (1991).
Hollenberg, S. M., Giguère, V., Segui, P. & Evans, R. M. Cell 49, 39–46 (1987).
Kamei, Y. et al. Cell 85, 403–414 (1996).
Kwok, R. P. S. et al. Nature 380, 642–646 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chakravarti, D., LaMorte, V., Nelson, M. et al. Role of CBP/P300 in nuclear receptor signalling. Nature 383, 99–103 (1996). https://doi.org/10.1038/383099a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/383099a0
This article is cited by
-
Natural compounds targeting nuclear receptors for effective cancer therapy
Cancer and Metastasis Reviews (2023)
-
Y08197 is a novel and selective CBP/EP300 bromodomain inhibitor for the treatment of prostate cancer
Acta Pharmacologica Sinica (2019)
-
CBP/p300: intramolecular and intermolecular regulations
Frontiers in Biology (2018)
-
Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer
BMC Cancer (2016)
-
Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer
Hormones and Cancer (2016)